Galmed Pharmaceuticals (FRA:GPH) Cyclically Adjusted Book per Share: €1,822.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GPH Galmed Pharmaceuticals Ltd FRA:GPH
29 GF Score
Price €2.74
! 2 Warning Signs
View Full Analysis

What is Galmed Pharmaceuticals Cyclically Adjusted Book per Share?

Galmed Pharmaceuticals FRA:GPH 29 Cyclically Adjusted Book per Share is €1,822.51 as of Mar. 2026. GuruFocus rates FRA:GPH with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Galmed Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2026 was €1.828. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1,822.51 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Galmed Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -10.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Galmed Pharmaceuticals was -9.80% per year. The lowest was -9.80% per year. And the median was -9.80% per year.

As of today (2026-07-16), Galmed Pharmaceuticals's current stock price is €2.736. Galmed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1,822.51. Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.


Galmed Pharmaceuticals  (FRA:GPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.736/1822.51
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Galmed Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Chart

Galmed Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 345.18 368.67 322.96 1,203.29

Galmed Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 694.70 526.31 679.44 1,203.29 1,822.51

FRA:GPH vs FBLG, SXTP, CELZ: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galmed Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


FRA:GPH
29GF Score
Galmed Pharmaceuticals Ltd FRA:GPH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Galmed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.828/330.2130*330.2130
=1.828

Current CPI (Mar. 2026) = 330.2130.

Galmed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201606 207.081 241.018 283.717
201609 206.522 241.428 282.470
201612 156.701 241.432 214.324
201703 114.103 243.801 154.545
201706 81.691 244.955 110.124
201709 77.183 246.819 103.261
201712 166.838 246.524 223.476
201803 137.888 249.554 182.455
201806 671.836 251.989 880.392
201809 664.709 252.439 869.499
201812 660.333 251.233 867.922
201903 642.402 254.202 834.492
201906 615.615 256.143 793.635
201909 600.855 256.759 772.749
201912 537.333 256.974 690.476
202003 491.644 258.115 628.973
202006 450.653 257.797 577.243
202009 386.051 260.280 489.777
202012 307.576 260.474 389.926
202103 320.029 264.877 398.969
202106 268.698 271.696 326.569
202109 230.396 274.310 277.350
202112 194.173 278.802 229.978
202203 159.165 287.504 182.809
202206 140.964 296.311 157.092
202209 113.614 296.808 126.401
202212 90.507 296.797 100.697
202303 79.993 301.836 87.514
202306 69.579 305.109 75.304
202309 43.617 307.789 46.795
202312 30.302 306.746 32.620
202403 23.425 312.332 24.766
202406 20.660 314.175 21.715
202409 11.023 315.301 11.544
202412 9.365 315.605 9.798
202503 6.914 319.799 7.139
202506 3.355 322.561 3.435
202509 2.972 324.800 3.022
202512 2.048 324.054 2.087
202603 1.828 330.213 1.828

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1,822.51 mean?
Galmed Pharmaceuticals (FRA:GPH) has a Cyclically Adjusted Book per Share of €1,822.51 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Galmed Pharmaceuticals and its competitors.
Is Galmed Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Galmed Pharmaceuticals' current Cyclically Adjusted Book per Share is €1,822.51. Overall, Galmed Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Galmed Pharmaceuticals' Cyclically Adjusted Book per Share compare to FBLG and SXTP?
Galmed Pharmaceuticals' Cyclically Adjusted Book per Share of €1,822.51 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Galmed Pharmaceuticals and its competitors. Galmed Pharmaceuticals's current Cyclically Adjusted Book per Share is €1,822.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galmed Pharmaceuticals stock overvalued right now?
Galmed Pharmaceuticals (FRA:GPH) has a current Cyclically Adjusted Book per Share of €1,822.51. The current Cyclically Adjusted Book per Share is €1,822.51. Galmed Pharmaceuticals' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Galmed Pharmaceuticals (FRA:GPH), the current Cyclically Adjusted Book per Share is €1,822.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galmed Pharmaceuticals Business Description

Other Exchanges GLMD:USA
Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
29GF Score

Get the complete analysis for FRA:GPH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price